[Comparative study of the intestinal spasmolytic properties of metoclopramide and metopimazine].
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001464:Barium / Q000494:pharmacology; D002712:Chlorides / Q000494:pharmacology; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007421:Intestine, Small / Q000187:drug effects*; D007540:Isonipecotic Acids / Q000494:pharmacology*; D008297:Male; D008787:Metoclopramide / Q000008:administration & dosage / Q000494:pharmacology*; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D010276:Parasympatholytics; D010640:Phenothiazines / Q000494:pharmacology*
D002712:Chlorides; D007540:Isonipecotic Acids; D010276:Parasympatholytics; D010640:Phenothiazines; D001464:Barium; D001285:Atropine; D006632:Histamine; D008787:Metoclopramide; D000109:Acetylcholine
Etude comparée des propriétés spasmolytiques intestinales du métoclopramide (1) et de la métopimazine (2).